Similar Papers

Paper Title
Journal
Date
Author
External validation of the PRECISE-DAPT score in an Asian cohort of patients with acute coronary syndrome post-percutaneous coronary intervention
R Y Fong ... A Lee
European Heart Journal | VOL. 42
R Y Fong, et. al.R Y Fong ... A Lee
12 Oct 2021
222-G Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (
Juan Gumuzio ... Veronique Calleja
Journal for ImmunoTherapy of Cancer | VOL. 11
Juan Gumuzio, et. al.Juan Gumuzio ... Veronique Calleja
31 Oct 2023
Abstract 4288: Inherited mutations in BRCA1 and BRCA2 in an unselected multi-ethnic cohort of Asian breast cancer patients and healthy controls from Malaysia
Wei Xiong Wen ... Alison Dunning
Cancer Research | VOL. 77
Wei Xiong Wen, et. al.Wei Xiong Wen ... Alison Dunning
01 Jul 2017
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients.
Yiqing Huang ... Boon Cher Goh
International Journal of Cancer | VOL. 150
Yiqing Huang, et. al.Yiqing Huang ... Boon Cher Goh
13 Oct 2021
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
A Perspective on the MARS2 Trial
Eric Lim ... Harvey Pass
Journal of Thoracic Oncology | VOL. -
Eric Lim, et. al.Eric Lim ... Harvey Pass
01 Jan 2025
Meeting Announcements
-
Journal of Thoracic Oncology | VOL. -
--
01 Jan 2025
Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer: Results From TROPiCS-03
Afshin Dowlati ... Saiama N Waqar
Journal of Thoracic Oncology | VOL. -
Afshin Dowlati, et. al.Afshin Dowlati ... Saiama N Waqar
01 Jan 2025
Editorial Board
-
Journal of Thoracic Oncology | VOL. -
--
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.